US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

190.52

+2.191.16%

Post-market: 190.520.00000.00%16:10 EDT

Volume:1.03M

Turnover:195.94M

Market Cap:9.43B

PE:30.18

High:190.93

Open:190.03

Low:188.82

Close:188.33

52wk High:199.05

52wk Low:130.25

Shares:49.50M

Float Shares:49.50M

Volume Ratio:0.86

T/O Rate:2.09%

Dividend:0.41

Dividend Rate:0.22%

EPS(TTM):6.31

EPS(LYR):-1.4940

ROE:24.54%

ROA:0.10%

PB:1.16

PE(LYR):-127.53

Loading ...

Overview Company News Filings

Freenome, Abbott announce FDA approval of SimpleScreen CRC

Gilead price target lowered to $165 from $166 at Morgan Stanley

Pacira transitions PCRX-201 to a U.S.-based manufacturing process

Argenx is Maintained at Neutral by Baird

Argenx price target raised to $932 from $867 at Baird

Legend Biotech Names Alan Bash Interim CEO After Ying Huang Resigns

Telix-Regeneron Radiopharma Deal and Lawsuit Could Be A Game Changer For Regeneron Pharmaceuticals (REGN)

Simply Wall St.

Gilead Sciences (GILD) Gets a Hold from RBC Capital

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Moderna Inc. Stock Falls 5.2%, Underperforms Peers

Amgen Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

The Scientist with 1,000 Patents Fueling a Drug Powerhouse

Argenx's Vyvgart Beat Impressive With Focus On Upcoming Myositis Data, RBC says

MT Newswires Live

Exchange-Traded Funds Higher as US Equities Advance After Midday

MT Newswires Live

Sector Update: Healthcare

MT Newswires Live

Argenx is Maintained at Market Outperform by Citizens

Amgen Says Strongly Disagrees with FDA'S Proposal to Withdraw Tavneos from the U.S. Market

Amgen : Submits Data to FDA Seeking Hearing on Tavneos Avacopan in Response to Withdrawal Proposal

THOMSON REUTERS

Amgen Inc: Strongly Disagrees with Fda's Proposal to Withdraw Tavneos from the U.S. Market

THOMSON REUTERS

RBC Raises Price Target on argenx to $1,025 From $945, Keeps Outperform Rating

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IBB/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"iShares Biotechnology ETF","latestPrice":190.52,"timestamp":1785268800000,"preClose":188.33,"halted":0,"volume":1032233,"hourTrading":{"tag":"盘后","latestPrice":190.52,"preClose":190.52,"latestTime":"16:10 EDT","volume":529,"amount":100792.33787999999,"timestamp":1785269419394,"change":0,"changeRate":0,"amplitude":0.002152},"delay":0,"changeRate":0.01162852439866191,"floatShares":49500000,"shares":49500000,"eps":6.311863,"marketStatus":"Post-Mkt","change":2.19,"latestTime":"07-28 16:13:49 EDT","open":190.03,"high":190.93,"low":188.82312,"amount":195936837.13186002,"amplitude":0.011187,"askPrice":191.9,"askSize":100,"bidPrice":189.09,"bidSize":1900,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1785283200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":188.33,"sharesOutstanding":49450000,"nav":188.173992,"aum":9352247402.4,"dividendRate":0.002172,"bidAskSpread":0.00038,"preHourTrading":{"tag":"盘前","latestPrice":189.6,"preClose":188.33,"latestTime":"09:27 EDT","volume":898,"amount":170329.52394,"timestamp":1785245220404,"change":1.27,"changeRate":0.006743,"amplitude":0.016036},"postHourTrading":{"tag":"盘后","latestPrice":190.52,"preClose":190.52,"latestTime":"16:10 EDT","volume":529,"amount":100792.33787999999,"timestamp":1785269419394,"change":0,"changeRate":0,"amplitude":0.002152},"volumeRatio":0.862611,"impliedVol":0.226,"impliedVolPercentile":0.4661},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":49500000,"roa":"0.10%","roe":"24.54%","lyrEps":-1.493977,"volumeRatio":0.862611,"shares":49500000,"dividePrice":0.4139,"high":190.93,"amplitude":0.011187,"preClose":188.33,"low":188.82312,"week52Low":130.25,"pbRate":"1.16","psRate":"226.90","week52High":199.05,"institutionHeld":0,"latestPrice":190.52,"committee":0.9,"eps":6.311863,"divideRate":0.002172,"volume":1032233,"delay":0,"ttmEps":6.311863,"open":190.03,"prevYearClose":168.77,"prevWeekClose":188.14,"prevMonthClose":190.19,"prevQuarterClose":190.19,"fiveDayClose":189.31,"twentyDayClose":189.79,"sixtyDayClose":168.69},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"},{"date":"2025-03-18","symbol":"IBB","amount":0.121169,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-18","defaultRemindTime":1742304600000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-03-18","currency":"USD","dateTimestamp":1742270400000,"payDate":"2025-03-21"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.0858219,"currency":"USD"},{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2654010379","title":"Freenome, Abbott announce FDA approval of SimpleScreen CRC","url":"https://stock-news.laohu8.com/highlight/detail?id=2654010379","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654010379?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:16","pubTimestamp":1785154580,"startTime":"0","endTime":"0","summary":"Freenome (FRNM) and Abbott (ABT) announced that the FDA has approved SimpleScreen CRC, a new blood-based screening option for colorectal cancer in ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/freenome-abbott-announce-fda-approval-of-simplescreen-crc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/freenome-abbott-announce-fda-approval-of-simplescreen-crc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRC","MRNX","LABU","BBP","BK4082","IDNA","LU0266512127.USD","TBXU","LU2324357040.USD","PSCH","LFSC","LU1691799644.USD","SG9999002232.USD","SG9999002224.SGD","BK4588","BMED","IHI","LU1721429402.USD","NVIB","SGXZ41872573.SGD","LU2133065610.SGD","BK4504","MRNY","FRTY","SYNB","LU0868494617.USD","MEDI","LU0170899867.USD","LU1061106388.HKD","XLVX","ABT","RSPH","IYH","PINK","IEIH","IBB","LU2112291526.USD","GNMX","LU1914381329.SGD","IE0002141913.USD","BK4213","FRNM","PJP","GDOC","TECB","LU2468319806.SGD","LU0266013472.USD","BK4585","LU1721429741.USD","TMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654315010","title":"Gilead price target lowered to $165 from $166 at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2654315010","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654315010?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:10","pubTimestamp":1785154254,"startTime":"0","endTime":"0","summary":"Morgan Stanley lowered the firm’s price target on Gilead (GILD) to $165 from $166 and keeps an Overweight rating on the shares. The firm updated it...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gilead-price-target-lowered-to-165-from-166-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gilead-price-target-lowered-to-165-from-166-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1037948541.HKD","BK4588","IBBQ","IE00BKVL7J92.USD","IE00B3T34201.USD","LU0320765992.SGD","LU0234570918.USD","LU1674673691.USD","IE00B7SZLL34.SGD","LU1430594728.SGD","LU1585245621.USD","BBH","IE00BSNM7G36.USD","SG9999015952.SGD","LU1066053197.SGD","BIB","SG9999015986.USD","LU1057294990.SGD","TMED","LU1571399168.USD","LU2324357040.USD","LU1934455863.HKD","LU0889565916.HKD","LU0965509283.SGD","BMED","IE0002270589.USD","LU1037948897.HKD","BK4566","LU2112291526.USD","TBXU","LU1674673428.USD","BK4532","LU0122379950.USD","LU1839511570.USD","MEDI","LU2468319806.SGD","LU1066051498.USD","GILD","IE00B19Z3B42.SGD","BK4578","IE00B19Z3581.USD","LU0289739699.SGD","BK4585","LU1778281490.HKD","LU0114720955.EUR","BK4139","LU0109394709.USD","LU0823416689.USD","BK4568","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654010362","title":"Pacira transitions PCRX-201 to a U.S.-based manufacturing process","url":"https://stock-news.laohu8.com/highlight/detail?id=2654010362","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654010362?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:10","pubTimestamp":1785154247,"startTime":"0","endTime":"0","summary":"Pacira (PCRX) announced that it has successfully transitioned PCRX-201, its investigational locally administered gene therapy for osteoarthritis of...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pacira-transitions-pcrx-201-to-a-u-s-based-manufacturing-process-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pacira-transitions-pcrx-201-to-a-u-s-based-manufacturing-process-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PCRX","SYNB","IBBQ","TBXU","LFSC","EES","GNOM","BK4588","CNCR","BK4007","IBB","FBT","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654017229","title":"Argenx is Maintained at Neutral by Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2654017229","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654017229?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:08","pubTimestamp":1785154080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ARGX/analyst-ratings(END) Dow Jones NewswiresJuly 27, 2026 08:08 ET","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","IBB","BK4585","IE00B2B36J28.USD","TBXU","IE0034235188.USD","BK4588","LU0320765992.SGD","IE00B4R5TH58.HKD","LU0889565916.HKD","FMED","IE0009355771.USD","LU1983260115.SGD","IE00BFTCPJ56.SGD","BK4139","LU2324357040.USD","ARGX","IE0002141913.USD","BK4505","LU0109394709.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654047014","title":"Argenx price target raised to $932 from $867 at Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2654047014","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654047014?lang=en_us&edition=fundamental","pubTime":"2026-07-27 19:16","pubTimestamp":1785150983,"startTime":"0","endTime":"0","summary":"Baird raised the firm’s price target on Argenx (ARGX) to $932 from $867 and keeps a Neutral rating on the shares. The firm updated its model follow...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/argenx-price-target-raised-to-932-from-867-at-baird-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/argenx-price-target-raised-to-932-from-867-at-baird-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","TBXU","IE0034235188.USD","BK4139","LU0889565916.HKD","IE00B2B36J28.USD","LU0320765992.SGD","LU0109394709.USD","BK4585","IE0009355771.USD","FMED","LU1983260115.SGD","IE00B4R5TH58.HKD","BK4505","ARGX","LU2324357040.USD","IE00BJT1NW94.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654193550","title":"Legend Biotech Names Alan Bash Interim CEO After Ying Huang Resigns","url":"https://stock-news.laohu8.com/highlight/detail?id=2654193550","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654193550?lang=en_us&edition=fundamental","pubTime":"2026-07-27 18:03","pubTimestamp":1785146636,"startTime":"0","endTime":"0","summary":"Legend Biotech names Alan Bash interim CEO after Ying Huang resignsLegend Biotech CEO Ying Huang resigned as CEO, stepped down from the board, effective July 24, 2026.Huang plans to stay on as an advi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nNDL6KM30B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU0321505868.SGD","TBXU","LU0306807586.USD","IE00BJT1NW94.SGD","LU1430594728.SGD","LU2237438978.USD","IE00B2B36J28.USD","LU0306806265.USD","FTXH","BK4532","MEMS","LU1670711123.USD","LU0823416689.USD","LU1585245621.USD","LU1974910355.USD","LU2468319806.SGD","REGN","LEGN","IE00BSNM7G36.USD","LU2133065610.SGD","LU0868494617.USD","BMY","LU1983299246.USD","LU2362541513.USD","BK4588","BK4505","LU1868836591.USD","BBH","LU1883839398.USD","LU1670710661.SGD","LU2360032135.SGD","LU1093756168.USD","LU0225284248.USD","LU0823434583.USD","LU0985481810.HKD","MEDI","LU2106854487.HKD","LU1917777945.USD","LU1670711040.USD","IHE","LU1323610961.USD","LU2242652126.USD","LU0267386448.USD","LU1868836757.USD","BK4585","CANC","IBB","LU0114720955.EUR","LU0096364046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654096238","title":"Telix-Regeneron Radiopharma Deal and Lawsuit Could Be A Game Changer For Regeneron Pharmaceuticals (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2654096238","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654096238?lang=en_us&edition=fundamental","pubTime":"2026-07-27 09:23","pubTimestamp":1785115400,"startTime":"0","endTime":"0","summary":"In July 2026, Telix Pharmaceuticals announced it had entered a collaboration with Regeneron Pharmaceuticals to co-develop and commercialize next-generation radiopharmaceutical cancer therapies, with Telix receiving an initial non-refundable US$40 million payment on signing.\nSoon after, Regeneron was hit with a securities class action lawsuit alleging misleading disclosures about a Phase III Fianlimab-Libtayo trial, highlighting legal and credibility questions around its oncology pipeline...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/telix-regeneron-radiopharma-deal-and-lawsuit-could-be-a-game","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/telix-regeneron-radiopharma-deal-and-lawsuit-could-be-a-game","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IBBQ","BBH","LU2362541273.HKD","REGN","IBB","LU2362540622.SGD","BK4588","LU2237438978.USD","TBXU","LU0882574055.USD","LU1974910355.USD","LU0114720955.EUR","LU0289739699.SGD","LU0823434583.USD","LU0823416689.USD","LU0320765992.SGD","BK4139","LU2106854487.HKD","LU1917777945.USD","LU0058720904.USD","LU0109394709.USD","LU0823434740.USD","LU2468319806.SGD","BK4585","LU0053666078.USD","LU2089984988.USD","LU2362541513.USD","LU0889565916.HKD","LU2023250504.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654054550","title":"Gilead Sciences (GILD) Gets a Hold from RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2654054550","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654054550?lang=en_us&edition=fundamental","pubTime":"2026-07-25 22:45","pubTimestamp":1784990714,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Brian Abrahams maintained a Hold rating on Gilead Sciences on July 23 and set a price target of $120.00. The company’s shares c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-gets-a-hold-from-rbc-capital-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-gets-a-hold-from-rbc-capital-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1037948541.HKD","LU0823416689.USD","LU1839511570.USD","TBXU","BK4207","LU0320765992.SGD","LU0708994859.HKD","LU1674673691.USD","MEDI","LU0965508806.USD","BK4532","SG9999015945.SGD","LU1037948897.HKD","LU0109394709.USD","BK4585","IE00B19Z3B42.SGD","LU1585245621.USD","LU2087621335.USD","GILD","LU0889565916.HKD","IE00BSNM7G36.USD","LU1934455194.USD","LU1778281490.HKD","LU0122379950.USD","LU0289739699.SGD","BK4550","LU1066053197.SGD","LU0861579265.USD","LU1674673428.USD","LU0965509283.SGD","SG9999015978.USD","LU2468319806.SGD","BBH","BK4568","LU1934455277.USD","LU1066051498.USD","BK4139","IE0002270589.USD","GSIB","SG9999015952.SGD","BMED","IBB","IE00BKVL7J92.USD","BIB","BK4566","LU1023059063.AUD","TMED","IBBQ","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654003206","title":"Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2654003206","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654003206?lang=en_us&edition=fundamental","pubTime":"2026-07-25 04:36","pubTimestamp":1784925360,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slid 1.18% to $129.31 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.05% to 7,411.98 and the Dow Jones Industrial Average  rising 0.46% to 51,947.25.The stock's fall snapped a two-day winning streak.Gilead Sciences Inc. closed 17.79% short of its 52-week high of $157.29, which the company achieved on February 11th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  rose 1.59% to $263.40, Pfizer Inc.  fell 0.16% to $24.54, and Abbott Laboratories  rose 2.29% to $103.06.Trading volume  remained 2.4 million below its 50-day average volume of 7.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled July 24, 2026.This content was created by MarketWatch, which ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509283.SGD","LU0861579265.USD","SG9999015945.SGD","LU1839511570.USD","GILD","LU1934455194.USD","IE00BSNM7G36.USD","LU0882574055.USD","LU1061106388.HKD","LU1674673691.USD","BBH","BIB","LU0823416689.USD","BK4532","LU0114720955.EUR","SG9999015952.SGD","IBBQ","LU0889565916.HKD","LU1023059063.AUD","LU1934455277.USD","IE00B3T34201.USD","LU0058720904.USD","BK4139","LU1674673428.USD","BK4583","LU1057294990.SGD","BK4566","BK4578","LU0109394709.USD","LU0965508806.USD","LU0965509101.SGD","IBB","LU1066051498.USD","SG9999015986.USD","BMED","IE00BKVL7J92.USD","LU1585245621.USD","LU1571399168.USD","LU2112291526.USD","LU2468319806.SGD","BK4588","LU1934455863.HKD","SG9999015978.USD","IE00B19Z3B42.SGD","BK4568","MEDI","IE00B19Z3581.USD","LU1430594728.SGD","IE0002270589.USD","IE00BZ1G4Q59.USD","LU0320765992.SGD","LU1778281490.HKD","LU2089984988.USD","LU0122379950.USD","TBXU","TMED","IE00B7SZLL34.SGD","LU1037948897.HKD","LU0965509010.AUD","BK4585","LU2324357040.USD","LU2087621335.USD","BK4550","LU1037948541.HKD","LU1066053197.SGD","LU0234570918.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654032089","title":"Moderna Inc. Stock Falls 5.2%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2654032089","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654032089?lang=en_us&edition=fundamental","pubTime":"2026-07-25 04:35","pubTimestamp":1784925300,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. shed 5.2% to $54.07 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.5% to 51,947.25 and the NASDAQ Composite Index falling 0.6% to 24,975.82.This was the stock's third consecutive day of losses.Moderna Inc. closed 36.8% below its 52-week high of $85.60, which the company achieved on July 6th.The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 1.6% to $263.40, Pfizer Inc. fell 0.2% to $24.54, and Gilead Sciences Inc. fell 1.18% to $129.31.Trading volume totaled 4.4 million, compared to the 50-day average of 7.4 million.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 24, 2026 16:35 ET Copyright  2026 Dow Jones & Company, Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","TMED","MRNA","IE00BZ1G4Q59.USD","LU1674673428.USD","LU1057294990.SGD","IE00B3T34201.USD","LU2112291526.USD","BK4583","IBBQ","BK4533","IDNA","BK4566","IE00B19Z3581.USD","LU0114720955.EUR","LU2468319806.SGD","MRNX","BBH","IBB","LU1934455194.USD","LU0965508806.USD","LU2089984988.USD","LU1037948541.HKD","LU0234570918.USD","LU0320765992.SGD","LU1571399168.USD","LU1585245621.USD","BK4551","LGHT","LU1066053197.SGD","BK4548","IE00B19Z3B42.SGD","LU1674673691.USD","MEDI","LU0109394709.USD","BK4534","BK4578","LU0965509010.AUD","LU1839511570.USD","BMED","SG9999015952.SGD","SG9999015978.USD","BIB","GILD","IE00BSNM7G36.USD","GNOM","LU2087621335.USD","BK4568","MRNY","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654032082","title":"Amgen Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2654032082","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654032082?lang=en_us&edition=fundamental","pubTime":"2026-07-25 04:35","pubTimestamp":1784925300,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  rose 1.22% to $376.04 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.05% to 7,411.98 and the Dow Jones Industrial Average  rising 0.46% to 51,947.25.This was the stock's second consecutive day of gains.Amgen Inc. closed 3.90% below its 52-week high of $391.29, which the company reached on March 2nd.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson  rose 1.59% to $263.40, Pfizer Inc.  fell 0.16% to $24.54, and AbbVie Inc.  rose 0.95% to $259.36.Trading volume  remained 237,584 below its 50-day average volume of 2.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled July 24, 2026.This content was created by MarketWatch, which is operate","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","IE0002141913.USD","BBH","PBE","LU0122379950.USD","IBB","BK4588","TBXU","LU1983299246.USD","LU0868494617.USD","LU0289739699.SGD","PJP","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU1571399168.USD","LU1057294990.SGD","LU2242646821.SGD","LU1023059063.AUD","BK4534","AMGN","LU0320765992.SGD","LU2242652126.USD","BIB","BK4139","BK4581","BK4599","LU2112291526.USD","LU1061106388.HKD","IE00B4R5TH58.HKD","04332","LU0058720904.USD","LU0109394709.USD","IE00B2B36J28.USD","LU2468319806.SGD","BK4585","IE00BJT1NW94.SGD","BK4533","SG9999001440.SGD","IE0009355771.USD","LU2089984988.USD","LU0889565916.HKD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654394350","title":"The Scientist with 1,000 Patents Fueling a Drug Powerhouse","url":"https://stock-news.laohu8.com/highlight/detail?id=2654394350","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654394350?lang=en_us&edition=fundamental","pubTime":"2026-07-25 01:40","pubTimestamp":1784914800,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals co-founder and chief scientific officer George Yancopoulos is more comfortable in a leather jacket than a suit -- so much so, his own team had to talk him into wearing one to the White House.He conceded, but not without adding a colorful tie, hand-painted by Nobel laureate Wally Gilbert. Yancopoulos isn't one to blend in.The meeting with President Trump in April was organized in part to tout Regeneron's latest invention: a gene therapy that restores hearing to children born with a rare genetic deafness, affecting fewer than 50 newborns a year in the U.S. Regeneron -- at Yancopoulos's urging -- decided to give it away, free.\"We did it to make a statement,\" said Yancopoulos, 66. \"We want to remind people that when people are sick, you pray for a miracle. And where do they come from?","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1917777945.USD","LU0289739699.SGD","BK4588","LU0109394709.USD","LU0823434583.USD","IBB","LU1974910355.USD","LU2023250504.SGD","LU0823416689.USD","LU0882574055.USD","LU2106854487.HKD","LU0053666078.USD","TBXU","LU0823434740.USD","LU2468319806.SGD","REGN","LU2362541273.HKD","LU0114720955.EUR","LU2237438978.USD","BBH","LU0889565916.HKD","BK4139","LU2362540622.SGD","BK4585","LU0320765992.SGD","LU2089984988.USD","LU2362541513.USD","IBBQ","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654003991","title":"Argenx's Vyvgart Beat Impressive With Focus On Upcoming Myositis Data, RBC says","url":"https://stock-news.laohu8.com/highlight/detail?id=2654003991","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654003991?lang=en_us&edition=fundamental","pubTime":"2026-07-25 01:22","pubTimestamp":1784913753,"startTime":"0","endTime":"0","summary":"Argenx's  Vyvgart posted a strong Q2 beat on organic demand in myasthenia gravis and chronic inflammatory demyelinating polyneuropathy, prefilled syringe uptake, and a label expansion, RBC Capital Markets said in a note emailed Friday.The firm highlighted that most payers have dropped serology testing requirements ahead of treatment, potentially removing an adoption barrier, while Japan results included a one-time benefit tied to a wholesaler distribution change.RBC said sequential growth topped prior-year trends, suggesting sales may be inflecting further ahead of a potential ocular myasthenia gravis label expansion.RBC noted the pivotals for both myositis and multifocal motor neuropathy are on track to read out in the second half of the year.RBC maintained its outperform rating and increased the price target to 1,025 from $945.Price: 918.54, Change: -6.06, Percent Change: -0.66","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4505","IE00B2B36J28.USD","IE0009355771.USD","BK4585","LU2324357040.USD","TBXU","LU0320765992.SGD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0109394709.USD","IE00B4R5TH58.HKD","FMED","BK4588","LU1983260115.SGD","IE0034235188.USD","BK4139","IBB","IE0002141913.USD","LU0889565916.HKD","ARGX","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654395340","title":"Exchange-Traded Funds Higher as US Equities Advance After Midday","url":"https://stock-news.laohu8.com/highlight/detail?id=2654395340","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654395340?lang=en_us&edition=fundamental","pubTime":"2026-07-25 01:11","pubTimestamp":1784913075,"startTime":"0","endTime":"0","summary":"Broad Market IndicatorsBroad-market exchange-traded funds IWM and IVV rose. Actively traded Invesco QQQ Trust (QQQ) eased 0.2%.US equity indexes rose as all sectors advanced in Friday's midday trading","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XLE","ARKY","FDN","XSD","SDS","SPYD","VHT.AU","UNG","SPGP","IGM","XLK","BTF","RTH.AU","RTH","XLY",".SPX","VDC","QQQ","SOXX","STCE","YMAX","SCHX","IYW","BETE","FAS","GLD","XLV","SLV",".DJI","USO",".IXIC","IYJ","BETH","FAZ","IYH","VIS","EETH","XLP","STT","BITO","IYK","XLF","GPIQ","NVIW.SI","XRT","ETH","XLI","IBB","IYE","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653087581","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2653087581","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653087581?lang=en_us&edition=fundamental","pubTime":"2026-07-24 20:58","pubTimestamp":1784897902,"startTime":"0","endTime":"0","summary":"Healthcare stocks were flat to higher premarket Friday, with the iShares Biotechnology ETF  inactive and the State Street Health Care Select Sector SPDR ETF  advancing by 0.4%.Tenet Healthcare  shares were up more than 17% after the company posted higher Q2 adjusted earnings and revenue, and raised its 2026 guidance.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0128526141.USD","LU0648000940.SGD","IE0034235188.USD","LU1201861165.SGD","LU0130103400.USD","IE00BGHQF748.EUR","LU0963586101.USD","FDN","LU2324357040.USD","BK4585","LABU","LU1894683348.USD","LU1894683264.USD","LU0061475181.USD","THC.AU","XLV","BK4581","STT","BK4185","THC","HCSG","IE00B3QW5Z07.USD","BK4137","IBB","BK4550","BK4135","XBI","LU0029874061.USD","BK4588","IE00B64PRP62.GBP","LU1883839398.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653108239","title":"Argenx is Maintained at Market Outperform by Citizens","url":"https://stock-news.laohu8.com/highlight/detail?id=2653108239","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653108239?lang=en_us&edition=fundamental","pubTime":"2026-07-24 20:28","pubTimestamp":1784896080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ARGX/analyst-ratings(END) Dow Jones NewswiresJuly 24, 2026 08:28 ET","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FMED","IE0009355771.USD","LU0109394709.USD","ARGX","IE00BJJMRZ35.SGD","IE0002141913.USD","IE00B4R5TH58.HKD","BK4588","BK4505","IE0034235188.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU1983260115.SGD","BK4139","LU2324357040.USD","BK4585","IE00BFTCPJ56.SGD","TBXU","IBB","LU0320765992.SGD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653084412","title":"Amgen Says Strongly Disagrees with FDA'S Proposal to Withdraw Tavneos from the U.S. Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2653084412","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653084412?lang=en_us&edition=fundamental","pubTime":"2026-07-24 20:13","pubTimestamp":1784895221,"startTime":"0","endTime":"0","summary":"BRIEF-Amgen Says Strongly Disagrees With FDA'S Proposal To Withdraw Tavneos From The U.S. MarketJuly 24 -Amgen IncAMGN.O:AMGEN : SUBMITS DATA TO FDA SEEKING HEARING ON TAVNEOS AVACOPAN IN RESPONSE TO WITHDRAWAL PROPOSALAMGEN INC: STRONGLY DISAGREES WITH FDA'S PROPOSAL TO WITHDRAW TAVNEOS FROM THE U.S. MARKETSource text: [ID:]Further company coverage:AMGN.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nFWN43Q0NS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4588","IBBQ","LU0320765992.SGD","BK4534","BBH","BIB","PBE","LU1057294990.SGD","LU1571399168.USD","LU0889565916.HKD","LU0868494617.USD","SG9999001440.SGD","LU2112291526.USD","BK4566","TBXU","LU2242646821.SGD","LU2089984988.USD","IE0009355771.USD","IE0002141913.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0122379950.USD","BK4533","LU1061106388.HKD","LU2468319806.SGD","AMGN","LU0058720904.USD","LU2242652126.USD","LU0289739699.SGD","LU1983299246.USD","BK4585","PJP","BK4139","LU0109394709.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU1023059063.AUD","IBB","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653608445","title":"Amgen : Submits Data to FDA Seeking Hearing on Tavneos Avacopan in Response to Withdrawal Proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=2653608445","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653608445?lang=en_us&edition=fundamental","pubTime":"2026-07-24 20:11","pubTimestamp":1784895089,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nFWN43Q0NS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B2B36J28.USD","IE0009355771.USD","LU1571399168.USD","LU1061106388.HKD","BK4585","BK4566","PBE","TBXU","LU0058720904.USD","LU2242652126.USD","LU0320765992.SGD","SG9999001440.SGD","LU1983299246.USD","LU2242646821.SGD","BBH","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU2468319806.SGD","LU2089984988.USD","BIB","LU0109394709.USD","BK4599","BK4533","LU0289739699.SGD","IE00B4R5TH58.HKD","LU1057294990.SGD","BK4588","BK4581","PJP","AMGN","BK4534","LU1023059063.AUD","BK4139","IBB","LU2112291526.USD","IE0002141913.USD","LU0889565916.HKD","IBBQ","LU0122379950.USD","LU0868494617.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653084459","title":"Amgen Inc: Strongly Disagrees with Fda's Proposal to Withdraw Tavneos from the U.S. Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2653084459","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653084459?lang=en_us&edition=fundamental","pubTime":"2026-07-24 20:11","pubTimestamp":1784895089,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nFWN43Q0NS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0289739699.SGD","LU2468319806.SGD","LU0889565916.HKD","LU1061106388.HKD","LU1023059063.AUD","IE00BFTCPJ56.SGD","BK4599","LU0868494617.USD","LU0058720904.USD","AMGN","LU2112291526.USD","LU1057294990.SGD","TBXU","BK4139","IE0002141913.USD","BK4534","PBE","BK4566","PJP","LU1571399168.USD","IE0009355771.USD","IE00B4R5TH58.HKD","BK4533","BBH","IE00BJT1NW94.SGD","BK4581","LU0320765992.SGD","LU0109394709.USD","LU2242646821.SGD","IBB","LU2242652126.USD","BK4588","LU0122379950.USD","BK4585","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","IBBQ","SG9999001440.SGD","BIB","LU1983299246.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653812010","title":"RBC Raises Price Target on argenx to $1,025 From $945, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2653812010","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653812010?lang=en_us&edition=fundamental","pubTime":"2026-07-24 19:48","pubTimestamp":1784893700,"startTime":"0","endTime":"0","summary":"argenx (ARGX) has an average rating of buy and mean price target of $1,091.36, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0889565916.HKD","IE00B4R5TH58.HKD","TBXU","BK4585","BK4505","FMED","IE0009355771.USD","LU1983260115.SGD","LU0109394709.USD","IE0002141913.USD","IE00B2B36J28.USD","LU2324357040.USD","ARGX","IE00BFTCPJ56.SGD","BK4588","BK4139","IBB","IE0034235188.USD","LU0320765992.SGD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}